Showing results (1771-1780 of 2,362) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|September 25, 2023
Status Cataplecticus Induced by an Abrupt Duloxetine Withdrawal-A Case ReportMarek Cierny, John Feemster, Mohsin Hamid, et al.Clinical Neuropharmacology|April 3, 2003
Cerebrovascular characterization of the novel nonpeptide endothelin-A receptor antagonist LU 208075Hartmut Vatter, Michael Zimmermann, Edda Weyrauch, et al.Clinical Neuropharmacology|April 3, 2003
Outcome of severe Guillain-Barré syndrome in children: comparison between untreated cases versus gamma-globulin therapyEli Shahar, Maxim LeidermanClinical Neuropharmacology|November 1, 2002
Comparison of intravenous immunoglobulin preparations on microglial function in vitro: more potent immunomodulatory capacity of an IgM/IgA-enriched preparationRefik Pul, Dan Nguyen, Ulrike Schmitz, et al.Clinical Neuropharmacology|November 1, 2002
Olanzapine for Huntington's disease: an open label studyRaphael M Bonelli, Franz A Mahnert, Gerald NiederwieserClinical Neuropharmacology|November 1, 2002
A patient with Cotard syndrome who showed an improvement in single photon emission computed tomography findings after successful treatment with antidepressantsSadayuki Hashioka, Akira Monji, Masayuki Sasaki, et al.Clinical Neuropharmacology|December 7, 2002
Sequential changes in the plasma concentration of risperidone following intentional overdoseHirofumi Nishikage, Takeshi Nakanishi, Yoshihiro Takamitsu, et al.Clinical Neuropharmacology|June 5, 2003
Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoringManuela Contin, Federica Provini, Paolo Martinelli, et al.Clinical Neuropharmacology|June 5, 2003
First clinical evaluation of ganstigmine in patients with probable Alzheimer's diseaseS S Jhee, Laura Fabbri, A Piccinno, et al.Pageof 237